NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ:LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173310&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
(TSX:WDO),(OTC US:WDOFF),(Other OTC:WDOFF), TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company“) is pleased to announce that Wesdome's board of directors has approved, subject to approval of the Toronto Stock Exchange (the “TSX“) the initiation of a Normal Course Issuer Bid (“NCIB“) to repurchase up
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin
Wesdome Gold Mines Announces Normal Course Issuer Bid GlobeNewswire October 21, 2025 TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company“) is pleased to announce that Wesdome's board of directors has approved, subject to approval of the Toronto Stock Exchange (the “TSX“) the initiation of
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010,
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is
(TSX:WDO),(OTC US:WDOFF),(Other OTC:WDOFF), All amounts are expressed in Canadian dollars unless otherwise indicated TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company“) today announces its operating results for the three and nine months ended September 30, 2025 (“Q3 2025” and “YTD 2025“). The Company is